Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-05-29

Clinical Trial Update: Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or Cancer [NA]

View source ↗

Summary

A Gynecologic Oncology Group trial evaluating protein expression as a potential diagnostic biomarker for cervical dysplasia and cervical cancer has completed. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Precancerous Condition, Stage 0 Cervical Cancer | NA | Status: COMPLETED